Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy

Overview of attention for article published in New England Journal of Medicine, November 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

news: 32 news outlets
blogs: 11 blogs
policy: 5 policy sources
twitter: 125 X users
patent: 32 patents

facebook: 12 Facebook pages
wikipedia: 11 Wikipedia pages
reddit: 3 Redditors
f1000: 1 research highlight platform
guideline: 3 clinical guideline sources

Readers on

mendeley: 1781 Mendeley

So far, Altmetric has seen 3 Reddit threads by 3 users.

Trabalho com saúde pública, mais especificamente análise de...

User tuliosarmento, in the Brasil é terra indígena subreddit, 30 Jan 2019

Trabalho com saúde pública, mais especificamente análise de medicamentos a serem incorporados em uma rede hospitalar, e de fato…

Interesting work, here’s the...

User Beo1, in the Reddit Science subreddit, 20 Aug 2018

Interesting work, here’s the paper: https://www.nejm.org/doi/full/10.1056/NEJMoa1702752

Phase III trials on Nusinersen, an antisense oligonucleotide drug that modifies pre-mrna splicing of SMN2 gene, improved motor functions of infant with spinal muscular dystrophy.

User gaprmaka, in the Reddit Science subreddit, 22 Nov 2017

This page shows the most recent Reddit threads that mention this research output. Click here to find out how to access more activity.